BD | Diabetes on the Net

Diabetes on the Net is intended for healthcare professionals

Company Profile

BD Diabetes Care have been specialising in the design and manufacture of insulin needles and syringes for over 90 years. BD’s culture of innovation and continuous improvement has enhanced the patient experience to enable better diabetes therapy and outcomes. BD and Me™ and BD Injection technique training programmes for HCPs and patients, have been designed to provide information on correct injection technique to better manage diabetes for those injecting1.

>1.Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013 Oct;39(5):445-53. doi: 10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22.

This resource page and the materials included have been organised and funded by BD

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.